Hypertension is a very prevalent cardiovascular (CV) disease risk factor in
developed countries. All current treatment guidelines emphasise the role o
f nonpharmacological interventions, including physical activity, in the tre
atment of hypertension. Since our most recent review of the effects of exer
cise training on patients with hypertension, 15 studies have been published
in the English literature. These results continue to indicate that exercis
e training decreases blood pressure (BP) in approximately 75% of individual
s with hypertension, with systolic and diastolic BP reductions averaging ap
proximately 11 and 8mm Hg, respectively. Women may reduce BP more with exer
cise training than men, and middle-aged people with hypertension may obtain
greater benefits than young or older people. Low to moderate intensity tra
ining appears to be as, if not more, beneficial as higher intensity trainin
g for reducing BP in individuals with hypertension. BP reductions are rapid
ly evident although, at least for systolic BP, there is a tendency for grea
ter reductions with more prolonged training. However, sustained BP reductio
ns are evident during the 24 hours following a single bout of exercise in p
atients with hypertension.
Asian and Pacific Island patients with hypertension reduce BP, especially s
ystolic BP more and more consistently than Caucasian patients. The minimal
data also indicate that African-American patients reduce BP with exercise t
raining. Some evidence indicates that common genetic variations may identif
y individuals with hypertension likely to reduce BP with exercise training.
Patients with hypertension also improve plasma lipoprotein-lipid profiles
and improve insulin sensitivity; to the same degree as normotensive individ
uals with exercise training. Some evidence also indicates that exercise tra
ining in hypertensive patients may result in regression of pathological lef
t ventricular hypertrophy. These results continue to support the recommenda
tion that exercise training is an important initial or adjunctive step that
is highly efficacious in the treatment of individuals with mild to moderat
e elevations in BP.